Impact of a standardized titration protocol with carvedilol in heart failure: safety, tolerability, and efficacy-a report from the GESICA registry
- PMID: 16025231
- DOI: 10.1007/s10557-005-1497-5
Impact of a standardized titration protocol with carvedilol in heart failure: safety, tolerability, and efficacy-a report from the GESICA registry
Abstract
Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) studied whether a standardized protocol for the initiation and titration of the beta-blocker carvedilol in a multicenter, open-label program would optimize beta-blocker use in heart failure (HF) patients. The program included: (1) the carvedilol initiation and titration period, and (2) long-term follow-up at 6 and 12 months. Of 1299 patients in the registry, 504 were excluded due to current therapy; of the remaining 795 eligible patients, 293 were excluded due to contraindications. Of the included patients with follow-up data (n = 316), 93.3% tolerated carvedilol initiation and 47.7% of the patients reached the target dose of 50 mg/day for a mean dose of 39 mg/day. Rates were comparable in the elderly (n = 83), of which 53% achieved a target dose for a mean dose of 43.08 mg/day. This protocol improved therapy rates and achieved target doses quickly (average of 4 visits). Concomitant medications did not have to be adjusted and there were low withdrawal rates (10%) and hospital admissions (7.2%) for HF. Patients were able to maintain carvedilol therapy at 6 and 12 months. These results indicate that a standardized titration protocol, as used in GESICA, for the initiation and titration of beta-blockers is well tolerated and may improve beta-blocker use in carefully selected heart failure patients.
Comment in
-
Do standardized beta-blocker titration protocols in heart failure improve compliance? The GESICA registry experience.Cardiovasc Drugs Ther. 2005 Mar;19(2):99-101. doi: 10.1007/s10557-005-3404-5. Cardiovasc Drugs Ther. 2005. PMID: 16025226 No abstract available.
Similar articles
-
Do standardized beta-blocker titration protocols in heart failure improve compliance? The GESICA registry experience.Cardiovasc Drugs Ther. 2005 Mar;19(2):99-101. doi: 10.1007/s10557-005-3404-5. Cardiovasc Drugs Ther. 2005. PMID: 16025226 No abstract available.
-
Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).Eur J Heart Fail. 2004 Jun;6(4):467-75. doi: 10.1016/j.ejheart.2003.12.019. Eur J Heart Fail. 2004. PMID: 15182773 Clinical Trial.
-
Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).Eur J Heart Fail. 2004 Jun;6(4):453-61. doi: 10.1016/j.ejheart.2004.02.003. Eur J Heart Fail. 2004. PMID: 15182771 Clinical Trial.
-
Clinical experience with carvedilol.J Hum Hypertens. 1993 Feb;7 Suppl 1:S16-20. J Hum Hypertens. 1993. PMID: 8098064 Review.
-
Carvedilol: use in chronic heart failure.Expert Rev Cardiovasc Ther. 2007 Jan;5(1):21-31. doi: 10.1586/14779072.5.1.21. Expert Rev Cardiovasc Ther. 2007. PMID: 17187454 Review.
Cited by
-
Use of carvedilol in hypertension: an update.Vasc Health Risk Manag. 2012;8:307-22. doi: 10.2147/VHRM.S31578. Epub 2012 May 18. Vasc Health Risk Manag. 2012. PMID: 22661898 Free PMC article. Review.
-
Carvedilol in the treatment of elderly patients with chronic heart failure.Clin Interv Aging. 2008;3(1):55-70. doi: 10.2147/cia.s1044. Clin Interv Aging. 2008. PMID: 18488879 Free PMC article. Review.
-
Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.Int J Chron Obstruct Pulmon Dis. 2015 Mar 5;10:515-23. doi: 10.2147/COPD.S79942. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 25784798 Free PMC article.
-
Tips and tricks on outpatient initiation and uptitration of beta-blockade in heart failure.Curr Heart Fail Rep. 2007 Jun;4(2):110-6. doi: 10.1007/s11897-007-0009-2. Curr Heart Fail Rep. 2007. PMID: 17521504 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous